Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Stanley

Orthopaedic Surgery of the Spine Parker, CO Medical Doctor

NPI 1831191931 CMS profile 37499

9949 S Oswego St, Suite 200, Parker, CO 80134

Open in the dashboard

General payments

$1,713,767

127 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Scott Stanley of Parker, CO is reported in the CMS Open Payments database as having received $1,713,767 across 127 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $189,728 28
2024 General $224,585 15
2023 General $245,951 12
2022 General $295,222 14
2021 General $380,047 23
2020 General $2,670 4
2019 General $375,563 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Stanley
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Scott Stanley were reported at $189,728. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Scott Stanley Orthopaedic Surgery of the Spine median Middle half National median
2019 $375,563 $2,106 $337–$18,608 $163
2020 $2,670 $1,213 $156–$15,082 $114
2021 $380,047 $1,834 $271–$15,617 $132
2022 $295,222 $2,015 $320–$17,036 $149
2023 $245,951 $1,925 $336–$14,599 $160
2024 $224,585 $2,110 $341–$12,483 $164
2025 $189,728 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Orthofix Medical, Inc. $1,707,864 87 payments
  2. Alphatec Spine, Inc $3,349 14 payments
  3. Seaspine Orthopedics Corporation $1,346 10 payments
  4. Centinel Spine, LLC $745 4 payments
  5. Medtronic, Inc. $128 3 payments
  6. Amgen Inc. $113 1 payment
  7. SI-BONE, Inc. $101 3 payments
  8. RTI Surgical, Inc. $50 1 payment
  9. Organogenesis Inc. $25 1 payment
  10. Becton, Dickinson and Company $18 1 payment
  11. Other $27 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $1,707,691 83 payments
  2. Travel and Lodging $3,496 9 payments
  3. Food and Beverage $2,580 35 payments
Products named General payments · program years 2019–2025
  1. FORZA PTC Spacer System $745,486 33 payments
  2. FORZA PEEK Spacer System $376,350 20 payments
  3. CONSTRUX - MINI PEEK VBR;CONSTRUX - MINI PTC Spinal Vertebral Body Replacement Device $303,326 8 payments
  4. PILLAR SA PTC $256,029 16 payments
  5. CONSTRUX - MINI PEEK VBR;CONSTRUX - MINI PTC Device $235,378 8 payments
  6. FORZA PTC Intervertebral Fusion Device With Bone Graft, Lumbar $211,999 8 payments
  7. Physio-Stim $186,196 12 payments
  8. Forza PTC Device $122,331 8 payments
  9. FORZA $16,082 3 payments
  10. CONSTRUX Mini PTC Spacer System $4,597 5 payments
  11. Other $13,720 65 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

110

Median for Orthopedic Surgery: 203

Drug cost

$766

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 56 $485
Methocarbamol Generic 21 $189
Tramadol Hcl Generic 19 $54
Prednisone Generic 14 $37

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$224,243

Of which drugs: $45,208

Medicare patients

164

Average age 73

Services billed

5,220

106 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Osteoporosis 39%
Ischemic heart disease 24%
Diabetes 23%
Depression 23%
COPD 20%
Chronic kidney disease 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, denosumab, 1 mg J0897 Office 11 660 $13,207

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

127 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record